As of 2024-12-15, the Intrinsic Value of Briacell Therapeutics Corp (BCT.TO) is
-0.66 CAD. This BCT.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.95 CAD, the upside of Briacell Therapeutics Corp is
-169.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.66 CAD
Intrinsic Value
BCT.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-0.66 - -0.66 |
-0.66 |
-169.70% |
P/E |
0.95 - 0.95 |
0.95 |
0.4% |
DDM - Stable |
(0.80) - (2.32) |
(1.56) |
-264.1% |
DDM - Multi |
(0.64) - (1.54) |
(0.92) |
-196.3% |
BCT.TO Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
34.37 |
Beta |
1.12 |
Outstanding shares (mil) |
36.18 |
Enterprise Value (mil) |
33.51 |
Market risk premium |
5.10% |
Cost of Equity |
12.39% |
Cost of Debt |
5.00% |
WACC |
8.04% |